CClinicalTrials.gg
CompletedNCT03763058CHUUpdated Aug 2, 2019Results posted

Music Intervention on Migraine Headaches

An interventional study of Music Therapy in Migraine Headache, sponsored by Association de Musicothérapie Applications et Recherches Cliniques. Completed at 1 site in Réunion. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-08-02.

Sponsored by Association de Musicothérapie Applications et Recherches Cliniques · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Migraine is a frequent pathology, highly linked to anxio-depressive factors. Non-drug approaches are part of the therapeutic arsenal. Music therapy is a recent discipline expanding in hospital services and specialised ambulatory centers. The main objective of this study is to assess the effect of " U " technique in receptive music therapy on migraine frequency, on patients suffering from episodic migraines, through " Music care " software home use. Secondary objectives are to assess this technique impact on migraine intensity, duration, emotional effect (HAD score), functional impact (HIT-6 score), and acute treatment administration. This is a monocentric prospective before-after study carried out in chronic pain department of the CHU Sud Reunion.

Read the detailed description

Despite converging evidence that music interventions are beneficial in a number of pain domains, additional research is needed to understand the impact of a music intervention on the debilitating nature of migraine headaches. Interestingly, a recently developed smartphone application called Music Care has been introduced as a music-intervention tool; however music type is controlled by the individual. A patient-controlled music intervention administered by Music Care has shown to alleviate negative psychological (e.g., depression) and physiological (e.g., pain and discomfort) outcomes associated with general chronic pain. However, no study has examined how music interventions administered via Music Care may be beneficial for individuals who experience migraines, thus potentially highlighting the effects of receptive music techniques in music therapy.

Therefore, the present investigation sought to examine the potential benefits of a patient-controlled, 3-month music intervention in individuals diagnosed with migraine headaches using the Music Care application. Patients from the university hospital center Sud Reunion (Saint Pierre, Reunion Island, France) within the Chronic Pain Consultation Group will be evaluated for inclusion in the study and will complete the 3-month music intervention. Participants will complete 1-2 sessions of listening to music per day, with a minimum of 15 sessions per month.

The following measures will be collected: the frequency of migraine attacks, the average duration of migraine attacks and the average intensity of migraine attacks. Patients will also rate levels of anxiety and depression associated with migraine headaches via the Hospital Anxiety and Depression Scale (HAD). The impact migraines have on everyday level of functioning will be evaluated using the Headache Impact Test (HIT-6).

This is a pilot study, non-randomized, single arm and single center study.

02

Conditions studied

  • Migraine Headache

Keywords

  • Migraine
  • Headache
  • Music intervention
  • Pain
  • Smartphone application
03

In context

Migraine Disorders

1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.

This study's enrollment of 20 is below the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

Association de Musicothérapie Applications et Recherches Cliniques is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with episodic migraine with at least 4 attacks per month
  • Patients with migraines with or without aura with diagnostic criteria per International Headache Society
  • Patients with a migraine for more than one year
  • Diagnosis age \< 50 years
  • Patients with an available internet connexion to access Music Care application
  • Patients with minimal knowledge in informatics
  • Patients who sign their inform consent

Exclusion criteria

Exclusion Criteria:

  • Patients aged less than 18 years
  • Patients with chronic migraine
  • Patients with epilepsy
  • Patients with a deficiency on auditive function
  • Patients with a disease that could be fatal within the study period.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Other
    Music intervention

    The music intervention is administered via a smartphone- (and computer-) based application called Music Care.

    Other: Music Therapy

Interventions

  • OtherMusic Therapy

    The music intervention is administered via a smartphone- (and computer-) based application called Music Care. The Music Care app is a receptive music intervention, allowing the patient to freely adjust the length of and choose the preferred style between different sequences of instrumental music. All musical pieces were recorded in high-quality recording studios with professional musicians. Music Care utilizes the "U" technique designed to gradually relax the listener. The "U" technique is implemented using a musical sequence of 20 minutes that was divided into 5 different musical pieces at 3 to 4 minutes each. Participants will complete 1-2 sessions of listening to music per day, with a minimum of 15 sessions per month.

06

What researchers measure

Primary outcomes

  1. Frequency of Migraine Attacks (Number of Days Per Month)

    All data related to migraine like frequency, duration, severity are to be collected in a diary questionnaire. Per ANAES (Agence nationale de l'accréditation et de l'évaluation en santé) recommendations, this means reduction of 50% on frequency of migraine attacks after 3-month treatment period. Comparison will be done between the number of days in the month prior the first music intervention and the number of days in the 3rd month of intervention.

    Time frame: 1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)

Secondary outcomes

  1. Duration of Migraine Attacks (Hours)

    The outcome is the mean duration of migraine attacks per month. Comparison will be done between the month prior the first music intervention and the 3rd month of intervention. The mean duration is calculated by summing the total duration during the month divided by the number of attacks in the month.

    Time frame: 1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)

  2. Number of Migraine Episodes With Severe Intensity

    This data is collected as mild, moderate or severe. The same analysis as the primary outcome will be done by severity. So the frequency of migraine attacks will be compared for each severity.

    Time frame: 1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)

  3. Impact of Migraines on Everyday Level of Functioning

    This outcome will be evaluated using the Headache Impact Test (HIT-6) score. The total score range is 36-78. A higher score indicates a worse impact of migraines on daily life. Comparison will be done between the score obtained before first music session and at the evaluation done after 3 months of music intervention.

    Time frame: 1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)

  4. Reduction on Anxiety and Depression

    This outcome will be evaluated using Hospital Anxiety and Depression Scale (HAD). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained before first music session and at the evaluation done after 3 months of music intervention.

    Time frame: 1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)

07

Results

Posted Jul 18, 2019
Limitations and caveats
* No control group * Future studies to explore music intervention compared to other therapeutic options * results to be interpreted with caution as headache symptoms are self-collected

Participant flow

Patients were recruited in Groupe Hospitalier Sud Réunion between 3-15 December 2018.

Participant flow — Overall Study
MilestoneMusic Intervention
Started20
Completed18
Not completed2

Outcome measures

PrimaryFrequency of Migraine Attacks (Number of Days Per Month)

All data related to migraine like frequency, duration, severity are to be collected in a diary questionnaire. Per ANAES (Agence nationale de l'accréditation et de l'évaluation en santé) recommendations, this means reduction of 50% on frequency of migraine attacks after 3-month treatment period. Comparison will be done between the number of days in the month prior the first music intervention and the number of days in the 3rd month of intervention.

Time frame:
1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)
Reported as:
Mean · Number of migraine per months
Frequency of Migraine Attacks (Number of Days Per Month)
Number of migraine per monthsMusic Intervention
Pre-treatment8.45 ± 3.03
Post-treatment5.65 ± 3.73
Statistical analysis
  • Music Intervention · Sign test · p = 0.012 · Mean difference (final values): -2.8
SecondaryDuration of Migraine Attacks (Hours)

The outcome is the mean duration of migraine attacks per month. Comparison will be done between the month prior the first music intervention and the 3rd month of intervention. The mean duration is calculated by summing the total duration during the month divided by the number of attacks in the month.

Time frame:
1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)
Reported as:
Mean · Hours
Duration of Migraine Attacks (Hours)
HoursMusic Intervention
Pre-treatment10.95 ± 16.84
Post-treatment5.5 ± 7.47
Statistical analysis
  • Music Intervention · Sign test · p = 0.002 · Mean difference (final values): -5.45
SecondaryNumber of Migraine Episodes With Severe Intensity

This data is collected as mild, moderate or severe. The same analysis as the primary outcome will be done by severity. So the frequency of migraine attacks will be compared for each severity.

Time frame:
1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)
Reported as:
Mean · Number of episodes
Number of Migraine Episodes With Severe Intensity
Number of episodesMusic Intervention
Pre-treatment2.9 ± 3.81
Post-treatment1.7 ± 1.72
Statistical analysis
  • Music Intervention · Sign test · p = 0.045 · Mean difference (final values): -1.2
SecondaryImpact of Migraines on Everyday Level of Functioning

This outcome will be evaluated using the Headache Impact Test (HIT-6) score. The total score range is 36-78. A higher score indicates a worse impact of migraines on daily life. Comparison will be done between the score obtained before first music session and at the evaluation done after 3 months of music intervention.

Time frame:
1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)
Reported as:
Mean · score on a scale
Impact of Migraines on Everyday Level of Functioning
score on a scaleMusic Intervention
Pre-treatment62.75 ± 6.12
Posttreatment59.1 ± 6.78
Statistical analysis
  • Music Intervention · Sign test · p = <0.001 · Mean difference (final values): -3.65
SecondaryReduction on Anxiety and Depression

This outcome will be evaluated using Hospital Anxiety and Depression Scale (HAD). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained before first music session and at the evaluation done after 3 months of music intervention.

Time frame:
1 month prior to intervention (pre-treatment) up to 3 months (post-treatment)
Reported as:
Mean · score on a scale
Reduction on Anxiety and Depression
score on a scaleMusic Intervention
Anxiety HAD pre-treatment9.05 ± 3.75
Anxiety HAD post-treatment7.4 ± 3.79
Depression HAD pre-treatment6.45 ± 3.88
Depression HAD post-treatment4 ± 3.46
Statistical analysis
  • Music Intervention · Sign test · p = <0.001 · Mean difference (final values): -4.15

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Music Intervention0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Music Intervention
Mean42 (19 to 63)
Sex: Female, Male
Sex: Female, Male(Participants)Music Intervention
Female17
Male3
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Music Intervention
Region of Enrollment
Region of Enrollment(participants)Music Intervention
Réunion20
08

Study locations

1 site
  • CHU de la Réunion
    Saint-Pierre, 97448, Réunion
09

References and documents

Publications

  • Guetin S, Ginies P, Siou DK, Picot MC, Pommie C, Guldner E, Gosp AM, Ostyn K, Coudeyre E, Touchon J. The effects of music intervention in the management of chronic pain: a single-blind, randomized, controlled trial. Clin J Pain. 2012 May;28(4):329-37. doi: 10.1097/AJP.0b013e31822be973. PubMed 22001666 ↗
  • Guetin S, Portet F, Picot MC, Defez C, Pose C, Blayac JP, Touchon J. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)]. Encephale. 2009 Feb;35(1):57-65. doi: 10.1016/j.encep.2007.10.009. Epub 2008 Feb 20. French. PubMed 19250995 ↗
  • Meister M, Einsle R, Brunner J, Rhyner K. [Psychofonia--a neurophysiologic music therapy in migraine]. Praxis (Bern 1994). 1999 May 20;88(21):946-9. German. PubMed 10412281 ↗
  • Koenig J, Oelkers-Ax R, Kaess M, Parzer P, Lenzen C, Hillecke TK, Resch F. Specific music therapy techniques in the treatment of primary headache disorders in adolescents: a randomized attention-placebo-controlled trial. J Pain. 2013 Oct;14(10):1196-207. doi: 10.1016/j.jpain.2013.05.006. Epub 2013 Jul 19. PubMed 23876282 ↗
  • Oelkers-Ax R, Leins A, Parzer P, Hillecke T, Bolay HV, Fischer J, Bender S, Hermanns U, Resch F. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain. 2008 Apr;12(3):301-13. doi: 10.1016/j.ejpain.2007.06.003. Epub 2007 Jul 30. PubMed 17659990 ↗

Study documents

  • Study protocol · Sep 21, 2018
  • Statistical analysis plan · Nov 15, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — This is not planned to share individual subjects data to other people.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03763058
Lead sponsor
Association de Musicothérapie Applications et Recherches Cliniques
Collaborators
Centre Hospitalier Universitaire de la Réunion
Responsible party
Sponsor
First posted
Dec 4, 2018
Start date
Dec 3, 2018
Primary completion
Mar 15, 2019
Completion
Mar 15, 2019
Results posted
Jul 18, 2019
Last update
Aug 2, 2019

Study contacts

Guilhem PARLONGUE, PhD
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion